Ruling Against Cigarette Warnings Could Impact Other FDA Labeling
This article was originally published in The Tan Sheet
Executive Summary
A judge’s opinion that requiring graphic images on cigarette packages unconstitutionally compels speech could affect FDA’s qualifications for supplement health claims and its off-label rules. FDA “carries the burden of proving” the required speech is truthful and accurate, says attorney Jonathan Emord.
You may also be interested in...
Sales Rep's Free Speech Challenge Of Off-Label Regs Boosted By Sorrell Ruling
The Supreme Court's ruling that Vermont's prescriber data mining law violates the First Amendment could help a pharma sales representative to overturn his conviction for promoting a drug for off-label uses.
FDA Off-Label Regs Face Cave-In Risk After Supreme Court Data-Mining Ruling
Lawyers have pored over the Supreme Court's decision overturning Vermont's prescriber data mining law to see how it may be applied to other forms of pharmaceutical marketing.
Rx Data Mining Opponents Will Need New Pitch After Supreme Court Strikes Down Vermont Law
The court affirms the Second Circuit's ruling that a Vermont statute prohibiting drug companies from using Rx data to market to doctors imposes an impermissible restriction on free speech.